AlphaFold predicted structure
KDSR · Q06136

Mean pLDDT
95.4/ 100
Very high
332 residues
Confidence breakdown
- Very high(≥ 90)87%
- Confident(70–90)13%
- Low(50–70)0%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
3-ketodihydrosphingosine reductase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BIALLELIC, autosomal or pseudoautosomalIchthyosis and erythrokeratoderma
BIALLELIC, autosomal or pseudoautosomalInherited bleeding disorders
BIALLELIC, autosomal or pseudoautosomalPalmoplantar keratoderma and erythrokeratodermas
BIALLELIC, autosomal or pseudoautosomalPalmoplantar keratodermas
BIALLELIC, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalerythrokeratodermia variabilis et progressiva 4
erythrokeratodermia variabilis
prostate carcinoma
blood platelet disease
neurodegenerative disease
lymphoid neoplasm
B-cell chronic lymphocytic leukemia
hereditary disease
plasma cell myeloma
breast carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
3-ketodihydrosphingosine reductase
Catalyzes the reduction of 3'-oxosphinganine (3-ketodihydrosphingosine/KDS) to sphinganine (dihydrosphingosine/DHS), the second step of de novo sphingolipid biosynthesis
KDSR · Q06136

Mean pLDDT
95.4/ 100
Very high
332 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0